The Effect of the Glucagon Suppressors Pramlintide and Exenatide on Postprandial Glucose Metabolism in Children With Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Exenatide (Primary) ; Pramlintide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 Apr 2017 Status changed from recruiting to completed.
- 11 Aug 2009 New trial record